Authors



Theodore A. Stern, MD

Latest:

The ABCs of Cardiac Screening and Electrocardiography

This comprehensive approach for assessing and addressing potential cardiac complications before prescribing psychotropics can enhance care.


Claire C. Holderness, MD, DFAPA

Latest:

Adding Insult to Narcissistic Injury: Comorbidity of Narcissistic Personality Disorder and Major Depressive Disorder

Diagnosing this intricate comorbidity demands a nuanced approach. Here's what you need to know.


Mehdi Farokhnia, MD, MPH

Latest:

An Update on GLP-1 Receptor Agonists as Pharmacotherapies for AUD

How effective are these agents for AUD treatment? An expert shares highlights from his 2024 ASCP Annual Meeting Pharmaceutical Pipeline Update presentation.


Jessica Peirce, PhD

Latest:

Treating Trauma and Addiction Simultaneously

1 in 6 people with opioid use disorder experience a new traumatic event every month, but no evidence-based treatment for trauma.


Terry R. Bard, DD

Latest:

Triage Trauma and Moral Distress

Mental health providers who battle a pandemic may find that it unsettles their deepest sense of self.


Amalia R. Sweet

Latest:

Can Epigenetics Promote Resilience Without Genetic Reductionism?

The emergence of epigenetic models has generated a surge of optimism, opening new possibilities for psychiatric intervention.


Petros Levounis, MD, MA

Latest:

Addiction’s Seat at the Table: An Interview With Outgoing APA President

Petros Levounis, MD, MA, talks addiction, buprenorphine, his year as president of the APA, and more at the 2024 Annual Meeting.


Bernard Biermann, MD, PhD

Latest:

Care of Youth Hospitalized With Somatic Symptom and Related Disorders

There is a growing effort to standardize the evaluation and management of pediatric SSRDs, which have been reported as the second most common reason for consultation after suicide assessments.


Josephine Collins, MSc

Latest:

Understanding Adult Fire Setting, Pyromania, and Arson

Fire setting is the current preferred term in the literature to describe acts of deliberately started fires regardless of their legal or diagnostic status.


Robert Hindman, PhD

Latest:

Safety Planning: An Essential Feature of Cognitive Behavior Therapy for Suicide Prevention

What is a safety plan, and how can clinicians use it to help patients with suicidal behavior?


Anika Sinha

Latest:

Smart Growth: the Case for Measuring Brain Capital

Brain health disorders cost the global economy more than $3 trillion per year in lost productivity. What can we do about it?


Laura Booi, PhD

Latest:

Boosting Brain Health After COVID-19: A Convergence Solution

How can we face the current pandemic while addressing the brain health crisis?


Antonella Santuccione Chadha, MD

Latest:

Mind-Body Resilience for Women: A Focus on Depression

Here’s why we should be paying special attention to women's depression treatment.


Steven Powell, MD

Latest:

The Application of Telemedicine in Treating Addiction for Older Adults

Isolated older adults may be especially vulnerable to addiction issues with the onset of the pandemic. Here’s how telemedicine can help.


Jason Goodman, MD

Latest:

A New CME: Continuing Moral Education

Every phase of the COVID-19 pandemic brings new ethical challenges.


Michael F. Myers, MD

Latest:

Psychiatry’s Gender Trouble

Michael F. Myers, MD, discusses issues of gender and sexuality, both today and in recent psychiatric history.


Jennifer Zaspel, MD

Latest:

Updates in Pediatric Boarding: A Review of National Pediatric Boarding Consensus Panel Recommendations

The development of the National Pediatric Boarding Consensus Panel guidelines attempts to provide hospitals suggestions for a safe, timely, and equitable standard of care for patients who are boarding.


Junyang Lou, MD, PhD

Latest:

The Fundamentals of QTc: Understanding Risks and Preventing Problems

Some psychiatric medications that can trigger Torsades de Pointes (TdP), a potentially fatal polymorphic ventricular tachycardia that arises during abnormal ventricular repolarization. Are you aware of the risk factors that increase risk of TdP?


Chukwunonso Azubuogu, MD

Latest:

Psychosis in the Patient With COVID-19: An Emerging Psychopathology?

"This pandemic represents an unprecedented time that requires a psychiatrist’s vigilance in identifying patients at risk for COVID-19–induced psychosis."


Kenneth Hung, MD

Latest:

Psychiatrists Call for End to Cruel and Harmful Immigration Policy

The Group for the Advancement of Psychiatry (America’s mental health think tank) calls for an end to the use of Title 42 to expel asylum seekers at the southern border. This policy places LGBTIQ asylum seekers in particular danger.


Andres Avellaneda Ojeda, MD

Latest:

Cannabis, Psychosis, and the Legal Implications: Chicken or Egg?

Explore the relationship between cannabis use and psychosis.


Cassandra Ann Gibson, MD, MS

Latest:

Bringing the Hospital Home: Meeting Teens in Crisis Where They Are

Learn more about a feasible, scalable, effective model of care that is a step away from the forced dichotomy of inpatient and outpatient care.


Robert Steel, PhD

Latest:

Vaccine Mandate Exemptions for Anxiety: Ethical and Practical Considerations

Does anxiety justify an exemption from vaccine mandates among health care workers?


Damir Huremović, MD, MPP

Latest:

A New CME: Continuing Moral Education

Every phase of the COVID-19 pandemic brings new ethical challenges.


Patricia Gherovici, PhD

Latest:

Latinx Psychoanalysis

A psychoanalyst shares her experience working with patients whose lives are marked by poverty, migration, and race and gender discrimination.


Amitai Ziv, MD

Latest:

Mental Health Responses to the Recent Conflict in Israel

What is the psychiatric impact of the current war in Gaza?


Jake Goodman, MD, MBA

Latest:

I Revealed That I Take Medication for My Mental Health to Millions Online. Here’s What Happened.

"When I was very young and dreaming of becoming a doctor, I never witnessed a physician open up about their mental health, let alone admit to taking medication for it..."


Bryson C. Lochte, MD

Latest:

Current Treatments for Cannabis Use Disorder

While there are no FDA-approved medications available for CUD, some studies show potential off-label utility in mitigating withdrawal and maintaining abstinence. Learn more in this CME article.


Kristel Carrington, MD

Latest:

Navigating New Terrain: Clinician Education at the Crossroads of Psychedelics and Medical Ethics

Psychedelics: it is time to integrate this treatment option into clinical care while holding fast to the principles of medical ethics.

© 2024 MJH Life Sciences

All rights reserved.